Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $3.36M | 0.01% |
+99,000
| New | +$3.53M |
|
1702
Immunome
IMNM
$3.09B
| $3.36M | 0.01% |
316,000
+304,700
| +2,696% | +$3.68M |
|
1703
STAAR Surgical
STAA
$1.3B
| $3.35M | 0.01% |
138,100
-165,800
| -55% | -$4.73M |
|
|
ZUO
1704
DELISTED
Zuora, Inc.
ZUO
| $3.35M | 0.01% |
338,000
+17,500
| +5% | +$170K |
|
|
DDL
1705
Dingdong
DDL
$523M
| $3.34M | ﹤0.01% |
1,018,975
-316,818
| -24% | -$1.23M |
|
1706
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $3.33M | ﹤0.01% |
+11,900
| New | +$3.36M |
|
1707
Vanguard FTSE Europe ETF
VGK
$31.1B
| $3.33M | ﹤0.01% |
52,500
+28,000
| +114% | +$1.87M |
|
1708
NCR Atleos
NATL
$3.47B
| $3.31M | ﹤0.01% |
97,700
-86,700
| -47% | -$2.63M |
|
|
LIF
1709
Life360
LIF
$4.17B
| $3.31M | ﹤0.01% |
80,300
+52,400
| +188% | +$2.31M |
|
|
MTLS
1710
Materialise
MTLS
$400M
| $3.31M | ﹤0.01% |
470,300
-96,074
| -17% | -$635K |
|
1711
International Bancshares
IBOC
$4.56B
| $3.31M | ﹤0.01% |
52,337
+10,519
| +25% | +$698K |
|
1712
Avis
CAR
$4.87B
| $3.3M | ﹤0.01% |
+40,980
| New | +$3.74M |
|
1713
Essent Group
ESNT
$6.25B
| $3.3M | ﹤0.01% |
60,600
+17,500
| +41% | +$1.02M |
|
|
SCWX
1714
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $3.28M | ﹤0.01% |
388,240
+212,900
| +121% | +$1.78M |
|
1715
Backblaze
BLZE
$1.18B
| $3.28M | ﹤0.01% |
545,513
+157,897
| +41% | +$1.07M |
|
1716
Comp X International
CIX
$385M
| $3.28M | ﹤0.01% |
125,249
-5,495
| -4% | -$160K |
|
|
TWFG
1717
TWFG Inc
TWFG
$1.45B
| $3.27M | ﹤0.01% |
+106,300
| New | +$3.3M |
|
1718
Murphy Oil
MUR
$4.96B
| $3.27M | ﹤0.01% |
108,100
+46,000
| +74% | +$1.48M |
|
1719
Worthington Enterprises
WOR
$2.87B
| $3.26M | ﹤0.01% |
81,300
-56,800
| -41% | -$2.3M |
|
|
CON
1720
Concentra Group Holdings
CON
$4.52B
| $3.26M | ﹤0.01% |
164,731
+151,166
| +1,114% | +$3.12M |
|
|
AMED
1721
DELISTED
Amedisys
AMED
| $3.25M | ﹤0.01% |
35,800
-84,301
| -70% | -$7.74M |
|
1722
Universal Corp
UVV
$1.11B
| $3.25M | ﹤0.01% |
59,211
-35,400
| -37% | -$1.9M |
|
1723
Daily Journal
DJCO
$831M
| $3.24M | ﹤0.01% |
5,711
+100
| +2% | +$53.5K |
|
1724
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
| $3.24M | ﹤0.01% |
136,800
+79,500
| +139% | +$1.93M |
|
1725
Expensify
EXFY
$210M
| $3.23M | ﹤0.01% |
965,200
-363,041
| -27% | -$976K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.